BriaCell Therapeutics BCTXW Stock
0.1 USD
{{ price }}
24.875004%
{{change_pct}}%
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
0 USD
LOW - HIGH [24H]
0.1
-
0.1 USD
VOLUME [24H]
9.46K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
BriaCell Therapeutics Price Chart
BriaCell Therapeutics BCTXW Financial and Trading Overview
| BriaCell Therapeutics stock price | 0.1 USD |
| Previous Close | 2.33 USD |
| Open | 5.19 USD |
| Bid | 4.78 USD x 1100 |
| Ask | 4.94 USD x 1100 |
| Day's Range | 2.55 - 2.69 USD |
| 52 Week Range | 2.55 - 2.69 USD |
| Volume | 883 USD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BCTXW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
BriaCell Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 2.69 USD |
| 52 Week Low | 2.55 USD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
BCTXW Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For BriaCell Therapeutics Stock
What is a current BCTXW stock price?
BriaCell Therapeutics BCTXW stock price today per share is 0.1 USD.
How to purchase BriaCell Therapeutics stock?
You can buy BCTXW shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BriaCell Therapeutics?
The stock symbol or ticker of BriaCell Therapeutics is BCTXW.
How many shares does BriaCell Therapeutics have in circulation?
The max supply of BriaCell Therapeutics shares is 0.
What is BriaCell Therapeutics Price to Earnings Ratio (PE Ratio)?
BriaCell Therapeutics PE Ratio is now.
What was BriaCell Therapeutics earnings per share over the trailing 12 months (TTM)?
BriaCell Therapeutics EPS is 0 USD over the trailing 12 months.